Table 3.
Rest of the world
| Country | Region | Total case number (n) | Prevalence (n/105) | Incidence (n/105/year) | Period covered by data | Particulars of the population | S | I | US | CT | MRI | HP | DNA | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Canada | Alberta, Ontario, British Columbia, Saskatchewan | 12b | 2001–2014 | R | n/a | n/a | n/a | n/a | n/a | n/a | n/a | Massolo [69] | ||
| Alberta, Ontario, British Columbia, Saskatchewan and the Territoriesa | 16b | 2002–2011 | R | n/a | n/a | n/a | n/a | n/a | n/a | n/a | Schurer [70] | |||
| Morocco | 1 | n/a | C | + | + | + | + | n/a | + | n/a | Maliki [72] | |||
| USA | Minnesota | 1 | 1977 | C | + | n/a | n/a | n/a | n/a | + | + | Yamasaki [71] | ||
| City of Chicago | 2 | 2003–2013 | (+) | (+) | n/a | (+) | n/a | + | (+) | Taxy [198] |
S serology, I diagnostic imaging (includes US, CT, MRI), US ultrasonography, CT computed tomography, MRI magnetic resonance imaging, HP histopathology, DNA DNA testing/genotyping, + positive diagnostic test using the particular method, (+) diagnostic test using the particular method possibly positive in some of the cases, n/a no information on diagnostic investigation using the particular method; aAdditional information obtained by personal communication with the corresponding author of the publication/Territories (Northwest Territories, Nunavut, Yukon) are coded the same in the registry; bauthors assume high probability of non-autochthonous infection; C: case report; R: data from an official registry